A Novel EPO Receptor Agonist Improves Glucose Tolerance via Glucose Uptake in Skeletal Muscle in a Mouse Model of Diabetes
Figure 5
HOMA analysis following a single dose of CNTO 530. CNTO 530 (0.3 mg/kg) was dosed IV to DIO mice (). Fourteen days later, (a) FBG and (b) fasting insulin levels were measured. (c) HOMA analysis was calculated for each group. The results are presented as mean ± SEM. *indicates a P value < .05. ***indicates a P value < .005.
